Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Schering presents new VEGF inhibitors

Feb. 6, 2003

New data on the anticancer efficacy of the nitrosourea derivative aranoza

Feb. 6, 2003

Safety of DEAE-rebeccamycin in patients with advanced hepatobiliary cancer

Feb. 5, 2003

Preclinical profile of SU-11248 and PK/PD data published

Feb. 5, 2003

2C3 antibody inhibits tumor growth by 75%

Feb. 5, 2003

New phase I trial for VNP-40101M in solid tumors

Feb. 5, 2003

Pyrimidine-based tyrosine kinase inhibitors covered by Merck patent

Feb. 5, 2003

Arizona State U. researchers design new combretastatin A3 prodrugs

Feb. 5, 2003

Cytovia scientists design caspase activators and apoptosis inducers

Feb. 5, 2003

Enrollment completed in phase III Tarceva trial in refractory NSCLC

Feb. 4, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 19, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...